
### [NCIT:C95597](http://purl.obolibrary.org/obo/NCIT_C95597)
**Label:** Pancreatic Glucagonoma

**Subclasses:** [NCIT:C65187](http://purl.obolibrary.org/obo/NCIT_C65187) (Malignant Pancreatic Glucagonoma), 

**Class expressions from DL-Learner:**

- Thing 54.08%
- [NCIT:C12573](http://purl.obolibrary.org/obo/NCIT_C12573) (Endocrine Cell of the Digestive System) 53.85%
- [NCIT:C9232](http://purl.obolibrary.org/obo/NCIT_C9232) (Weight Change) 51.92%
- [NCIT:C45981](http://purl.obolibrary.org/obo/NCIT_C45981) (Presence of a Hormonal Syndrome) 51.92%
- [NCIT:C45980](http://purl.obolibrary.org/obo/NCIT_C45980) (Absence of a Hormonal Syndrome) 51.92%
- [NCIT:C3445](http://purl.obolibrary.org/obo/NCIT_C3445) (Weight Loss) 51.92%
- [NCIT:C32885](http://purl.obolibrary.org/obo/NCIT_C32885) (Islet Cell) 51.92%
- [NCIT:C32052](http://purl.obolibrary.org/obo/NCIT_C32052) (Alpha Cell) 51.92%
- [NCIT:C2987](http://purl.obolibrary.org/obo/NCIT_C2987) (Diarrhea) 51.92%
- [NCIT:C36285](http://purl.obolibrary.org/obo/NCIT_C36285) (Endocrine System Finding) 39.20%
- [NCIT:C36285](http://purl.obolibrary.org/obo/NCIT_C36285) (Endocrine System Finding) and (not ([NCIT:C39807](http://purl.obolibrary.org/obo/NCIT_C39807) (Mucinous Tubular and Spindle Cell Carcinoma of the Kidney))) 39.20%
- [NCIT:C36285](http://purl.obolibrary.org/obo/NCIT_C36285) (Endocrine System Finding) and (not ([NCIT:C39806](http://purl.obolibrary.org/obo/NCIT_C39806) (NONO-TFE3 Fusion Protein Expression))) 39.20%
- [NCIT:C36285](http://purl.obolibrary.org/obo/NCIT_C36285) (Endocrine System Finding) and (not ([NCIT:C39805](http://purl.obolibrary.org/obo/NCIT_C39805) (PSF-TFE3 Fusion Protein Expression))) 39.20%
- [NCIT:C36285](http://purl.obolibrary.org/obo/NCIT_C36285) (Endocrine System Finding) and (not ([NCIT:C39803](http://purl.obolibrary.org/obo/NCIT_C39803) (PRCC-TFE3 Fusion Protein Expression))) 39.20%
- [NCIT:C36285](http://purl.obolibrary.org/obo/NCIT_C36285) (Endocrine System Finding) and (not ([NCIT:C39802](http://purl.obolibrary.org/obo/NCIT_C39802) (Renal Cell Carcinoma Associated with inv(X)(p11;q12)))) 39.20%


